Skip to main content

Table 2 Hazard ratios for death and MACCE associated with treatment strategies

From: Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China

  MT group (N = 913) PCI group (N = 1305) CABG group (N = 899)
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Death
 Crude Model 1.00 (ref) 0.33 (0.27, 0.40)  < 0.0001 0.34 (0.27, 0.42)  < 0.0001
 Multivariate adjusted Model 1.00 (ref) 0.40 (0.32, 0.51)  < 0.0001 0.33 (0.26, 0.44)  < 0.0001
 Crude Model 3.03 (2.51, 3.66)  < 0.0001 1.00 (ref) 1.03 (0.81, 1.30) 0.8396
 Multivariate adjusted Model 2.50 (1.98, 3.16)  < 0.0001 1.00 (ref) 0.83 (0.62, 1.12) 0.2215
MACCE
 Crude Model 1.00 (ref)   0.66 (0.58, 0.75)  < 0.0001 0.48 (0.41, 0.57)  < 0.0001
 Multivariate adjusted Model 1.00 (ref)   0.71 (0.60, 0.84)  < 0.0001 0.48 (0.39, 0.57)  < 0.0001
 Crude Model 1.52 (1.33, 1.73)  < 0.0001 1.00 (ref) 0.73 (0.62, 0.86) 0.0001
 Multivariate adjusted Model 1.41 (1.20, 1.66)  < 0.0001 1.00 (ref) 0.67 (0.55, 0.81)  < 0.0001
  1. MACCE major adverse cardiac and cerebrovascular events, HR hazard ratios, MT medical treatment, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting